Literature DB >> 24976106

Increases in beta-lipoproteins in hyperlipidemic and dyslipidemic dogs are associated with increased erythrocyte osmotic fragility.

Erica Behling-Kelly1, Rebekah Collins-Cronkright.   

Abstract

BACKGROUND: The capacity of RBCs to traverse endothelium and deliver oxygen to tissues is dependent on a mechanically stable yet flexible plasma membrane. The lipid composition of the RBC membrane is crucial in maintaining its structure and fluidity. Lacking a nucleus and having minimal synthetic capacity, RBCs are exquisitely sensitive to changes in plasma lipids.
OBJECTIVE: The objective of this study was to investigate the effects of plasma lipids on RBC fragility in hyperlipidemic and dyslipidemic dogs.
METHODS: Osmotic fragility of RBCs, plasma lipoprotein fractions, and cholesterol and phospholipid content of RBC membranes were measured in hyperlipidemic, dyslipidemic, and healthy control dogs. Osmotic fragility of normal canine RBCs incubated in phosphate-buffered saline and in both intact and lipid-depleted plasma from diabetic dogs was also measured.
RESULTS: RBCs from hyperlipidemic and dyslipidemic dogs with diabetes mellitus and dogs treated with glucocorticoids were significantly more fragile than RBCs from healthy control dogs. RBCs from hyperlipidemic dogs with cholestatic disease tended to be more stable relative to RBCs from controls. RBC osmotic fragility was positively correlated with beta-lipoprotein levels, but was only weakly correlated with serum cholesterol concentration. Incubation in plasma from hyperlipidemic diabetic dogs rendered RBCs from healthy dogs osmotically fragile, whereas lipid-depleted plasma from the same diabetic dogs had no effect.
CONCLUSIONS: RBCs from hyperlipidemic and dyslipidemic dogs are osmotically fragile, and fragility is highly correlated with increases in beta-lipoproteins. Future studies are planned to address the consequences of lipid-induced fragility and subclinical hemolysis on endothelial cells, platelets, and coagulation.
© 2014 American Society for Veterinary Clinical Pathology and European Society for Veterinary Clinical Pathology.

Entities:  

Keywords:  Canine; RBC; cholesterol; lipid

Mesh:

Substances:

Year:  2014        PMID: 24976106     DOI: 10.1111/vcp.12155

Source DB:  PubMed          Journal:  Vet Clin Pathol        ISSN: 0275-6382            Impact factor:   1.180


  6 in total

1.  Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat-another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats.

Authors:  Marta Soltesova Prnova; Lucia Kovacikova; Karol Svik; Stefan Bezek; Zübeyir Elmazoğlu; Cimen Karasu; Milan Stefek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-05       Impact factor: 3.000

2.  Increased erythrocytic osmotic fragility in anemic domestic shorthair and purebred cats.

Authors:  Claudia Tritschler; Keijiro Mizukami; Karthik Raj; Urs Giger
Journal:  J Feline Med Surg       Date:  2015-05-28       Impact factor: 2.015

3.  Sex-specific hepatic lipid and bile acid metabolism alterations in Fancd2-deficient mice following dietary challenge.

Authors:  Elizabeth S Moore; Erin K Daugherity; David I Karambizi; Bethany P Cummings; Erica Behling-Kelly; Deanna M W Schaefer; Teresa L Southard; Joseph W McFadden; Robert S Weiss
Journal:  J Biol Chem       Date:  2019-08-21       Impact factor: 5.157

4.  Evaluation of metabolic profile and C-reactive protein concentrations in brachycephalic dogs with upper airway obstructive syndrome.

Authors:  Paola Gianella; Roberta Caccamo; Claudio Bellino; Enrico Bottero; Federica Fietta; Silvia Roncone; Fabio Ostanello; Marco Pietra; Paolo Buracco
Journal:  J Vet Intern Med       Date:  2019-08-27       Impact factor: 3.333

5.  Blood donor obesity is associated with changes in red blood cell metabolism and susceptibility to hemolysis in cold storage and in response to osmotic and oxidative stress.

Authors:  Kelsey Hazegh; Fang Fang; Marjorie D Bravo; Johnson Q Tran; Marcus O Muench; Rachael P Jackman; Nareg Roubinian; Lorenzo Bertolone; Angelo DʼAlessandro; Larry Dumont; Grier P Page; Tamir Kanias
Journal:  Transfusion       Date:  2020-11-04       Impact factor: 3.157

6.  Spectrophotometry and Ultracentrifugation for Measurement of Plasma Lipids in Dogs with Diabetes Mellitus.

Authors:  E C Seage; K J Drobatz; R S Hess
Journal:  J Vet Intern Med       Date:  2017-11-29       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.